Cargando…

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common malignancies globally with poor prognosis. Cancer-associated fibroblasts (CAFs) play multiple functions in the regulation of tumorigenesis, metastasis and therapeutic resistance of cancer. The current study aimed to explore the role of CAFs-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Jianzhong, Tian, Wen, Zheng, Bigeng, Zeng, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637486/ https://www.ncbi.nlm.nih.gov/pubmed/37960718 http://dx.doi.org/10.1097/MD.0000000000035938

Ejemplares similares

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis
por: Wang, Anmei, et al.
Publicado: (2021)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
por: Bu, Fan, et al.
Publicado: (2022)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma
por: Zeng, Tao, et al.
Publicado: (2023)

Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients
por: Bai, Zhenzi, et al.
Publicado: (2020)

Identification of pyroptosis-related gene signature for predicting prognosis of patients with pancreatic cancer using bioinformatics
por: Xu, Zhongbo, et al.
Publicado: (2022)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma
por: Deng, Benyuan, et al.
Publicado: (2020)

Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma
por: Li, Juanjuan, et al.
Publicado: (2023)

Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma
por: Xu, Dapeng, et al.
Publicado: (2022)

Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma
por: Qian, Hong, et al.
Publicado: (2021)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients
por: Wu, Bo, et al.
Publicado: (2021)

Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer
por: Liu, Zhi-Yang, et al.
Publicado: (2023)

A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
por: Huang, Qian-Rong, et al.
Publicado: (2021)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhang, Zhiquan, et al.
Publicado: (2019)

Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022)

Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
por: Wang, Lei, et al.
Publicado: (2023)

Identification and verification of an exosome-related gene risk model to predict prognosis and evaluate immune infiltration for colorectal cancer
por: Shao, Huan, et al.
Publicado: (2023)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

A prognostic signature associated with cell senescence predicts survival outcomes and strongly associates with immunotherapy and chemotherapy response in breast cancer
por: Pan, Tao, et al.
Publicado: (2023)

Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022)

The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma
por: Yang, Sen, et al.
Publicado: (2023)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis
por: Lu, Shan, et al.
Publicado: (2023)

Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma
por: Gong, Youwei, et al.
Publicado: (2020)

Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma
por: Zhou, Mi, et al.
Publicado: (2022)

A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer
por: Hu, Yuanyuan, et al.
Publicado: (2023)

Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
por: Li, Zhengtian, et al.
Publicado: (2021)

Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer
por: Wu, Zhengyuan, et al.
Publicado: (2021)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Shi, Xinhui, et al.
Publicado: (2021)

A novel gene signature derived from the CXC subfamily of chemokine receptors predicts the prognosis and immune infiltration of patients with lung adenocarcinoma
por: Deng, Kun, et al.
Publicado: (2022)

Increased Serum Levels of Macrophage Inflammatory Protein-3α and Cystatin A Predict a Poor Prognosis of Nasopharyngeal Carcinoma
por: Cai, Yonglin, et al.
Publicado: (2014)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mb5haf0u4qklmgt3st81tm5otv